New Delhi [India], May 27 (ANI): Dismissing the reports of health risks from Hydroxychloroquine (HCQ) as per simmering reports cited by the World Health Organisation (WHO), Shekher Mande, Director General of the Council of Scientific and Industrial Research (CSIR), India, said on Wednesday t
New Delhi [India], May 21 (ANI): Three drug trials to combat COVID-19 have started and seven are in the process, said Council of Scientific and Industrial Research (CSIR) Director-General (DG) Dr Shekhar C Mande on Thursday.
New Delhi [India], May 13 (ANI): The AYUSH Ministry and the Council of Scientific and Industrial Research (CSIR) are working together on validating four Ayush formulations against COVID-19 and the trials will start within one week.
New Delhi [India], May 12 (ANI): In a record time of just 36 days a non-invasive BiPAP Ventilator 'SwasthVayu' has been developed by CSIR - National Aerospace Laboratories (NAL), Bangalore, a constituent of lab of CSIR to treat COVID-19 patients.
New Delhi [India], May 8 (ANI): The Council for Scientific and Industrial Research (CSIR) is leading the fight against Covid-19 using multi-pronged approach and multiple models of engagement.On one hand, CSIR labs themselves are developing technologies and products and are working with indus
New Delhi [India], May 8 (ANI): The Council of Scientific and Industrial Research (CSIR), through its New Millennium Indian Technology Leadership Initiative (NMITLI) program, has approved a multi-institutional project to develop human monoclonal antibodies (hmAbs) that can neutralize coronav
New Delhi [India], May 8 (ANI): The Council for Scientific and Industrial Research (CSIR) has received approval from Drug Controller General of India (DGCI) for its two clinical trial drugs - 'favipiravir' and 'phytopharmaceutical' - to combat coronavirus.
Hyderabad (Telangana) [India], May 8 (ANI): The Council of Scientific and Industrial Research (CSIR), under its flagship New Millennium Indian Technology Leadership Initiative programme (NMITLI), has sanctioned a project to develop human monoclonal antibodies as therapy for COVID-19 infectio
New Delhi [India], May 7 (ANI): The Council for Scientific and Industrial Research (CSIR) is exploring a native herb as a biological medicine or "phytopharmaceutical ", which is already being tested as medicine for dengue, for its efficacy to combat COVID-19.
New Delhi [India], May 7 (ANI): With the clinical trial of Ayush medicines beginning on Thursday, the Council of Scientific and Industrial Research (CSIR) Director-General Shekhar Mande said that the time is absolutely ripe currently to try out some of the traditional Ayurvedic formulations
New Delhi [India], May 7 (ANI): The National Research Development Corporation (NRDC) has prepared a 'Compendium of Indian Technologies for Combating COVID-19 (Tracing, Testing and Treating)'.
New Delhi [India], May 7 (ANI): The clinical trials of Ayush medicines on health workers and those working in COVID-19 high-risk areas have begun today, Union Health Minister Dr Harsh Vardhan said on Thursday.